Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics.
D000661:Amphetamine / Q000494:pharmacology / Q000627:therapeutic use*; D001519:Behavior / Q000187:drug effects; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000494:pharmacology / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000378:metabolism; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D008774:Methylphenidate; D000661:Amphetamine; D003913:Dextroamphetamine; D004298:Dopamine